888-969-2592
Kalkine 0
countryflagCA

CareRx Corp

Healthcare CA CRRX

2.71CAD
0.13(5.04%)

Last update at 2025-05-08T16:00:00Z

Day Range

2.592.71
LowHigh

52 Week Range

1.102.43
LowHigh

Fundamentals

  • Previous Close 2.58
  • Market Cap114.14M
  • Volume21900
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA21.68M
  • Revenue TTM366.55M
  • Revenue Per Share TTM6.20
  • Gross Profit TTM 109.93M
  • Diluted EPS TTM-0.12

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -35.89600M -23.73500M -18.30100M -39.58100M -37.71400M
Minority interest - - - - 0.19M
Net income -34.35300M -22.73000M -18.18300M -45.67700M -31.09300M
Selling general administrative 34.43M 25.13M 20.68M 19.07M 20.45M
Selling and marketing expenses - - - - -
Gross profit 109.93M 75.28M 47.05M 39.38M 35.10M
Reconciled depreciation 20.07M 15.39M 11.46M 9.32M 9.65M
Ebit 7.91M 4.71M -2.93800M -2.78500M -27.03400M
Ebitda 27.98M 20.11M 8.52M 6.54M -17.38800M
Depreciation and amortization 20.07M 15.39M 11.46M 9.32M 9.65M
Non operating income net other - - - - -
Operating income 7.91M 4.71M -2.93800M -2.78500M -6.56100M
Other operating expenses 374.09M 257.82M 163.61M 127.12M 130.30M
Interest expense 15.22M 14.49M 1.22M 23.67M 7.38M
Tax provision -1.54300M -1.00500M -0.11800M 6.10M -4.22200M
Interest income 0.28M 16.83M 4.92M 21.05M 10.66M
Net interest income -14.94300M -14.58900M -2.95200M -24.34600M -7.38500M
Extraordinary items - 0.00000M -0.07900M 16.37M 1.87M
Non recurring - - - - -
Other items - - - - -
Income tax expense -1.54300M -1.00500M -0.11800M 6.10M -3.32600M
Total revenue 381.73M 262.63M 162.20M 124.63M 123.74M
Total operating expenses 102.30M 70.47M 48.46M 41.88M 41.66M
Cost of revenue 271.79M 187.35M 115.14M 85.24M 88.64M
Total other income expense net -43.80700M -28.44900M -15.36300M -36.79600M -31.15300M
Discontinued operations - - -0.07900M 16.36M 1.76M
Net income from continuing ops -34.35300M -22.73000M -18.18300M -45.67700M -34.38800M
Net income applicable to common shares -34.35300M -22.73000M -18.26200M -29.32200M -33.62900M
Preferred stock and other adjustments - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 231.89M 264.54M 282.82M 156.11M 87.08M
Intangible assets 44.33M 52.95M 54.57M 35.33M 18.74M
Earning assets - - - - -
Other current assets 1.96M 2.56M 3.52M 1.64M 1.25M
Total liab 150.37M 200.08M 200.53M 144.81M 107.04M
Total stockholder equity 81.53M 64.46M 82.29M 11.30M -19.96100M
Deferred long term liab - - - - -
Other current liab 20.97M 23.40M 18.50M 20.86M 10.63M
Common stock 323.30M 299.78M 283.46M 189.78M 141.11M
Capital stock 323.30M 299.78M 283.46M 189.78M 141.11M
Retained earnings -282.68800M -277.28300M -242.93000M -220.20000M -201.93800M
Other liab - 10.97M 17.39M 21.73M 18.44M
Good will 70.01M 70.01M 92.11M 51.74M 27.24M
Other assets - - - - 0.00000M
Cash 7.71M 28.37M 35.62M 19.62M 0.06M
Cash and equivalents - 28.37M 35.62M 19.62M 0.06M
Total current liabilities 62.45M 63.89M 52.97M 43.35M 68.02M
Current deferred revenue - - - 17.32M 6.86M
Net debt 89.81M 106.85M 89.95M 62.57M 66.15M
Short term debt 12.37M 10.01M 1.27M 6.08M 45.63M
Short long term debt 9.92M 7.41M 0.73M 4.25M 44.27M
Short long term debt total 97.52M 135.22M 125.57M 82.19M 66.22M
Other stockholder equity 33.62M 41.96M 41.76M 41.73M 40.87M
Property plant equipment - 52.39M 38.17M 21.14M 20.05M
Total current assets 65.41M 89.18M 95.25M 45.19M 19.11M
Long term investments - 0.00000M 2.71M 2.71M 1.95M
Net tangible assets - -58.50900M -64.40000M -75.76400M -65.93700M
Short term investments - - - - -
Net receivables 36.09M 37.26M 38.11M 15.35M 12.55M
Long term debt 57.15M 99.37M 111.97M 71.95M 12.99M
Inventory 19.66M 20.30M 17.99M 8.58M 5.24M
Accounts payable 29.11M 30.48M 33.21M 16.41M 11.76M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 7.30M - - -18.38300M -14.38700M
Additional paid in capital - - - - -
Common stock total equity - - - 189.78M 141.11M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - -
Deferred long term asset charges - - - - -
Non current assets total 166.48M 175.36M 187.57M 110.92M 67.97M
Capital lease obligations 30.79M 28.44M 18.73M 9.62M 8.95M
Long term debt total - 125.22M 130.16M 79.72M 20.58M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -16.59800M -93.17700M -4.17100M 33.83M -6.27700M
Change to liabilities 0.82M 15.00M -2.76500M 1.16M -4.41500M
Total cashflows from investing activities -16.59800M -93.17700M -4.17100M 33.83M -6.27700M
Net borrowings -5.28900M 30.35M 18.54M -51.76200M 5.10M
Total cash from financing activities -12.98900M 101.91M 23.50M -40.12100M -0.31500M
Change to operating activities 0.31M -5.16900M 3.57M 0.25M -0.35700M
Net income -34.35300M -22.73000M -18.26200M -29.30700M -31.09300M
Change in cash -7.25400M 16.00M 19.56M 0.06M 0.06M
Begin period cash flow 35.62M 19.62M 0.06M 0.00000M 0.00000M
End period cash flow 28.37M 35.62M 19.62M 0.06M 0.00000M
Total cash from operating activities 22.33M 7.27M 0.23M 6.36M 6.59M
Issuance of capital stock 1.01M 80.86M 0.00000M 18.73M -
Depreciation 20.07M 15.39M 11.46M 9.32M 9.65M
Other cashflows from investing activities -2.98500M -86.06100M -0.07400M 38.02M 0.17M
Dividends paid 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Change to inventory -1.99700M -2.83300M 0.49M -0.52500M 1.27M
Change to account receivables 1.51M -10.72100M 2.54M -1.02800M 1.97M
Sale purchase of stock 1.01M 80.86M - 11.34M 0.46M
Other cashflows from financing activities -8.70700M 51.69M 42.49M -1.79200M 6.62M
Change to netincome 35.98M 18.33M 3.35M 26.49M 31.78M
Capital expenditures 13.61M 7.12M 1.96M 3.50M 4.45M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.64M -3.72700M 3.69M -0.14200M -1.53200M
Stock based compensation 4.57M 2.67M 2.52M 2.30M 3.00M
Other non cash items 32.96M 16.67M 1.00M 17.20M 26.57M
Free cash flow 8.72M 0.15M -1.72600M 2.86M 2.14M

Peer Comparison

Sector: Healthcare Industry: Medical Care Facilities

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CRRX
CareRx Corp		 0.13 5.04% 2.71 - 11.17 0.31 1.42 0.54 7.95
DNTL
dentalcorp Holdings Ltd		 0.14 1.62% 8.80 - 14.68 1.05 0.89 1.88 14.19
SIA
Sienna Senior Living Inc		 0.04 0.23% 17.31 43.79 36.90 1.67 3.83 2.82 18.48
WELL
WELL Health Technologies Corp		 0.11 2.89% 3.91 17.23 18.12 1.39 1.42 1.78 5.49
EXE
Extendicare Inc		 0.44 3.21% 14.13 14.07 15.70 0.58 7.49 0.71 7.52

Reports Covered

Stock Research & News

View All

Profile

CareRx Corporation, together with its subsidiaries, provides pharmacy services to seniors homes and other congregate care settings in Canada. The company offers medication management, technology, and program solutions. It serves long-term care homes, retirement homes, assisted living facilities, and group homes. The company was formerly known as Centric Health Corporation and changed its name to CareRx Corporation in June 2020. CareRx Corporation was incorporated in 2001 and is based in Toronto, Canada.

CareRx Corp

320 Bay Street, Toronto, ON, Canada, M5H 4A6

Key Executives

Name Title Year Born
Mr. David Murphy Pres, CEO & Director NA
Mr. Andrew Mok Chief Financial Officer NA
Mr. Puneet Khanna Chief Operating Officer NA
Mr. Paul Rakowski Sr. VP of Corp. Devel., Gen. Counsel, Chief Privacy Officer and Corp. Sec. NA
Ms. Adrianne Sullivan Campeau Chief People & Culture Officer NA
Mr. Ryan Stempfle VP & GM of Western Canada for the Specialty Pharmacy Division NA
Mr. Puneet Khanna CEO, President & Director NA
Mr. Paul Rakowski Senior VP of Corporate Development, General Counsel, Chief Privacy Officer & Corporate Secretary NA
Mr. Travis Featherstone Senior VP of Western Operations & System Integration NA
Ms. Suzanne Brand Chief Financial Officer NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.